scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JSBMB.2003.07.001 |
P698 | PubMed publication ID | 14623538 |
P50 | author | Lesley Fallowfield | Q23772391 |
P2093 | author name string | Valerie Jenkins | |
Tony Howell | |||
Valerie Shilling | |||
P2507 | corrigendum / erratum | Corrigendum to “The effects of hormone therapy on cognition in breast cancer” [J. Steroid Biochem. Mol. Biol. 86 (2003) 405–412] | Q57937840 |
P433 | issue | 3-5 | |
P304 | page(s) | 405-412 | |
P577 | publication date | 2003-09-01 | |
P1433 | published in | The Journal of Steroid Biochemistry and Molecular Biology | Q15708871 |
P1476 | title | The effects of hormone therapy on cognition in breast cancer | |
P478 | volume | 86 |
Q48014012 | A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy |
Q38747069 | Acute memory deficits in chemotherapy-treated adults. |
Q36528154 | Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage |
Q37585300 | Breast cancer treatment and cognitive function: the current state of evidence, underlying mechanisms and potential treatments |
Q57192800 | Cancer-related cognitive impairment in breast cancer survivors: An examination of conceptual and statistical cognitive domains using principal component analysis |
Q48284056 | Changes in perceived attentional function in women following breast cancer surgery |
Q28566058 | Cholesterol-promoted synaptogenesis requires the conversion of cholesterol to estradiol in the hippocampus |
Q38088668 | Clearing the air: a review of our current understanding of "chemo fog". |
Q35164117 | Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults |
Q58606275 | Cognitive Effects of Aromatase and Possible Role in Memory Disorders |
Q35660927 | Cognitive changes associated with endocrine therapy for breast cancer. |
Q43730922 | Cognitive dysfunction in people with cancer |
Q44859258 | Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls |
Q37157773 | Cognitive functioning in breast cancer survivors: a controlled comparison |
Q43484591 | Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors |
Q42704792 | Decision-making impairments in breast cancer patients treated with tamoxifen |
Q36932994 | Effect of endocrine therapy on quality of life and cognitive functions in patients with breast cancer |
Q48334506 | Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients. |
Q53132333 | Efficacy and safety of aromatase inhibitors in early breast cancer. |
Q38901804 | Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies. |
Q36684067 | Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level |
Q41442004 | Inhibition of oestrogen biosynthesis induces mild anxiety in C57BL/6J ovariectomized female mice |
Q36458593 | Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy? |
Q37782342 | Is Systemic Anti-Cancer Therapy Neurotoxic? Does Chemo Brain Exist? And Should We Rename It? |
Q37061881 | Letrozole Potentiates Mitochondrial and Dendritic Spine Impairments Induced by β Amyloid |
Q35616166 | Long-term consequences of estrogens administered in midlife on female cognitive aging |
Q37354647 | Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: a review |
Q51888707 | Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models. |
Q37139476 | Neuropsychological sequelae of non-central nervous system cancer and cancer therapy |
Q45111650 | Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy |
Q36436653 | Prognostic factors in paediatric anaplastic large cell lymphoma: role of ALK. |
Q37309638 | Protective actions of sex steroid hormones in Alzheimer's disease |
Q33570551 | Psychometric analysis of the Patient Assessment of Own Functioning Inventory in women with breast cancer |
Q47745329 | Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study. |
Q46458007 | Self-reported cognitive impairment after breast cancer treatment in young women from the ELIPPSE40 cohort: the long-term impact of chemotherapy |
Q39061531 | Sex-Dependent Regulation of Aromatase-Mediated Synaptic Plasticity in the Basolateral Amygdala. |
Q44863330 | Short Introduction and History |
Q46342146 | Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study |
Q30959013 | Structure-function-behavior relationship in estrogen-induced synaptic plasticity |
Q45924447 | Study of the cognitive effects of chemotherapy: considerations in selection of a control group. |
Q21146752 | Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system |
Q39212333 | Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature. |
Q44700581 | Tamoxifen disrupts consolidation and retrieval of morphine-associated contextual memory in male mice: interaction with estradiol. |
Q38653422 | The Impact of Endocrine Therapy on Cognitive Functions of Breast Cancer Patients: A Systematic Review. |
Q33636517 | The Working Memory and Dorsolateral Prefrontal-Hippocampal Functional Connectivity Changes in Long-Term Survival Breast Cancer Patients Treated with Tamoxifen |
Q57937840 | Corrigendum to “The effects of hormone therapy on cognition in breast cancer” [J. Steroid Biochem. Mol. Biol. 86 (2003) 405–412] | main subject | P921 |
Search more.